A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616]
-
* Corresponding author: Ronald J Hogg spnsg@lonestarhealth.com
- Equal contributors
BMC Nephrology 2004, 5:3 doi:10.1186/1471-2369-5-3
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 09 Apr 2003 | |
| Reviewer's Report | john feehally | 14 Apr 2003 | |
| Reviewer's Report | Joseph Grande | 08 May 2003 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 19 Jan 2004 |
| Reviewer's Report | john feehally | 24 Feb 2004 | |
| Reviewer's Report | Joseph Grande | 26 Feb 2004 | |
| Resubmission - Version 4 | Manuscript | Author's comment | 24 Mar 2004 |
| Published | 25 Mar 2004 |